In consultation: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Consultation end date

Consultation end date

Type

Type

Guidance programme

Showing 1 to 10 of 19

TitleConsultationTypeConsultation end date
Ertugliflozin in a triple therapy regimen for treating type 2 diabetes [ID1160]Review proposal consultationTechnology appraisal guidance
Heart failure - sacubitril valsartan [ID822]Review proposal consultationTechnology appraisal guidance
Empagliflozin for treating chronic heart failure with reduced ejection fraction [ID3826]Review proposal consultationTechnology appraisal guidance
Tirzepatide for treating type 2 diabetes [ID3938]Review proposal consultationTechnology appraisal guidance
Empagliflozin in combination therapy for treating type 2 diabetesReview proposal consultationTechnology appraisal guidance
Ertugliflozin as monotherapy and in dual therapy for treating type 2 diabetes [ID1158]Review proposal consultationTechnology appraisal guidance
Dapagliflozin in triple therapy regimens for treating type 2 diabetes [ID962]Review proposal consultationTechnology appraisal guidance
Diabetes (type 2) - canagliflozin, dapagliflozin and empagliflozin (monotherapy) [ID756]Review proposal consultationTechnology appraisal guidance
Dapagliflozin for treating heart failure with reduced ejection fraction [ID1656]Review proposal consultationTechnology appraisal guidance
Canagliflozin in combination therapy for treating type 2 diabetesReview proposal consultationTechnology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All